Definitive Contract 75F40120C00168
Award Date 9/29/20
Potential Completion Date 9/29/23
Potential Value $1.3M
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Cost No Fee
Place of Performance
Austria
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services Food and Drug Administration awarded a definitive contract valued at $831,964 to Research Center Pharmaceutical Engineering GmbH. The firm fixed price contract is to provide services in support of the project titled "OCT for Real-Time Monitoring of Coating Process Dynamics & Product Quality" and will involve work by the prime contractor and its parent organization, Technische Universitaet Graz. The contract has a period of performance...
- This definitive, firm fixed-price contract was awarded by the Department of Health and Human Services Food and Drug Administration (FDA) to CFD Research Corporation, a for-profit organization, to develop a multiscale computational framework for assessing the bioequivalence of orally inhaled drugs. The $499,761 contract does not have a set-aside designation. The original solicitation was a Broad Agency Announcement (BAA) seeking research and development to advance FDA's mission of protecting...
- This is a $950,450 cost-plus-fixed-fee contract awarded by the Food and Drug Administration (FDA) to CFD Research Corporation, a small business, to develop a Computational Fluid Dynamics (CFD)-Physiologically-Based Pharmacokinetic (PBPK) framework to support the bioequivalence evaluation of ophthalmic drugs. The contract is part of the FDA's Broad Agency Announcement (BAA) for research and development to advance regulatory science and innovation, with no set-aside used. CFD Research...
- This is a $661,012.30 Firm Fixed Price contract awarded by the Food and Drug Administration (FDA), a civilian federal agency, to Simvantage GMBH, a for-profit limited liability company based in Graz, Austria. The contract is for the purpose of "Combining Machine Learning and Mechanistic Models to Create a Digital Framework for Rapidly Designing Continuous Bioprocess Operations" and has a period of performance ending on September 21, 2027. The contract was awarded on September 15,...
- The U.S. Food and Drug Administration (FDA) awarded a $4,400,000.00 Cost Plus Fixed Fee contract to Continuus Pharmaceuticals, Inc. to support the "ADVANCEMENT OF INTEGRATED CONTINUOUS MANUFACTURING (ICM) UNIT OPERATIONS." This definitive contract does not have a set-aside designation and is scheduled to be completed by September 29, 2019. The contract is part of the FDA's efforts to advance integrated continuous manufacturing unit operations, which is a major program focus area for...
- This federal contract was awarded by the Department of Health and Human Services Food and Drug Administration (FDA) to the Universitat ST. Gallen, doing business as Hochschule FÜR Wirtschafts-, Rechts- UND Sozialwissenschaften (Hsg), an educational institution. The contract is a Firm Fixed Price definitive contract with a potential value of $764,418.19 and a completion date of September 29, 2023. The contract was awarded under the FDA's Broad Agency Announcement (BAA) for Advanced Regulatory...
- This is a $1,387,320.00 firm fixed price delivery order awarded by the Food and Drug Administration (FDA) to Research Triangle Institute (RTI International), a non-profit research organization. The contract is for evaluating differences in High Performance Hybrid Composite (HPHC) yield due to hardware changes resulting from long-term end use. This work supports the FDA's regulatory responsibilities. The contract does not have a set-aside designation. RTI International has received other...
- This is a $1,904,355.00 definitive cost-no-fee contract awarded by the Food and Drug Administration (FDA), a civilian government agency, to the Institute Of Quantitative Systems Pharmacology, a non-profit organization. The contract is for basic and applied research with two key objectives: (1) to test the hypothesis that variabilities in nanoparticle (NP) properties and tumor targets cause uncertainties in "FORMULA", and (2) to develop computational models to predict the...
- This federal contract award to The Trustees of Princeton University, valued at $2,692,771.30, is for an Integrated Platform for Continuous RNA Nanoparticle Formulation and Drying. The award was made by the Food and Drug Administration (FDA) and is not associated with a set-aside program. The contract supports research and development to advance regulatory science in areas of interest to the FDA, as outlined in a Broad Agency Announcement (BAA) solicitation. Key subcontractors include Seran...
- The U.S. Food and Drug Administration (FDA) awarded a firm fixed price purchase order contract worth $106,055.00 to Siemens Industry Software Inc., doing business as Siemens PLM Software, for a new license of the company's gPROMS or equal flowsheet modeling and simulation software. The software will be used to study emerging pharmaceutical manufacturing technologies and includes capabilities for steady-state and dynamic process modeling, parameter estimation, and optimization across a range of...